Found: 13
Select item for more details and to access through your institution.
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3587, doi. 10.3390/jcm9113587
- By:
- Publication type:
- Article
Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol.
- Published in:
- International Journal of COPD, 2012, v. 7, p. 375, doi. 10.2147/COPD.S31100
- By:
- Publication type:
- Article
Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0285606
- By:
- Publication type:
- Article
Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01943-z
- By:
- Publication type:
- Article
Randomized Double-Blind Controlled Trial of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2017, v. 196, n. 5, p. 656, doi. 10.1164/rccm.201612-2518LE
- By:
- Publication type:
- Article
Randomized Double-Blind Controlled Trial of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
- Published in:
- 2017
- By:
- Publication type:
- clinical trial
Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day.
- Published in:
- Journal of Asthma & Allergy, 2017, v. 10, p. 35, doi. 10.2147/JAA.S111712
- By:
- Publication type:
- Article
Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 833, doi. 10.1002/ejhf.2491
- By:
- Publication type:
- Article
Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 821, doi. 10.1002/ejhf.2478
- By:
- Publication type:
- Article
Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 1, p. 230, doi. 10.1002/ejhf.2386
- By:
- Publication type:
- Article
Oral ferroportin inhibitor VIT‐2763: First‐in‐human, phase 1 study in healthy volunteers.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 68, doi. 10.1002/ajh.25670
- By:
- Publication type:
- Article
Roflumilast in Asian patients with COPD: A randomized placebo-controlled trial.
- Published in:
- Respirology, 2011, v. 16, n. 8, p. 1249, doi. 10.1111/j.1440-1843.2011.02038.x
- By:
- Publication type:
- Article
Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.
- Published in:
- European Journal of Heart Failure. Supplements, 2022, v. 24, n. 1, p. 230, doi. 10.1002/ejhf.2386
- By:
- Publication type:
- Article